Check out companies making headlines in the midday deal: Novo Nordisk – Share after the Food and Drug Administration said on Friday that the US of Novo Nordisk weight loss injections was resolved after two years or more rose 4.9%. HIMS & HERS HEALTH – Telehealth Stock, offering compound Wegovy and Ozempic, plummeted 22.9% after the FDA announced that the Semaglutide shortage has been “solved.” HIMS & HERS sells cheaper versions of GLP-1 drugs by combining ingredients to customize treatments, but compounding pharmacies are only allowed to sell branded drugs during shortages. Under the FDA’s decision, HIMS & HERS may use its compounded facility until May 22nd. Alibaba rose 5.7%, reaching a height of 52 weeks after GameStop CEO and billionaire investor Ryan Cohen increased his position in China’s E. -The Commerce giant amounts to roughly $1 billion worth of stakes, the Wall Street Journal reported Thursday. UnitedHealth – Stocks fell 8.6% after the Wall Street Journal reported that the insurance company was under investigation by the Department of Justice. The probe is evaluating UnitedHealth’s protocol to document diagnoses that could lead to additional payments for Medicare Advantage plans, the report says. In a statement, UnitedHealth said it was “outrageous” that the insinuation of its work was injustice. The company’s stock price has fallen by more than 20% over the past three months as it navigates the turbulent period. Reservation Holds – The stock rose 2%, exceeding the expected $36.03 expected from analysts voted by LSEG after the online travel booking platform reported fourth quarter adjusted revenue of $41.55 per share. Revenue also surpassed expectations, reaching $5.47 billion, compared to a consensus estimate of $5.48 billion. Dropbox – Cloud Software Company’s stock lost about 13.8% in quarterly mixed results. The block reported a total non-GAAP margin of 83.1% in the fourth quarter. Meanwhile, the company’s adjusted revenue and revenue exceeded consensus forecasts. Mercadolibre – Latin American e-commerce stocks added 8.5% after strong results in the fourth quarter. The company recorded earnings per share of $12.61 to revenue of $6.06 billion. Analysts were expecting $7.93 per share against revenue of $5.888 billion per LSEG. Akamai Technologies – Shares fell over 18% after Akamai’s first quarter guidance became weaker than expected. The cloud computing company sought adjusted revenues of $1.54 to $1.59 per share, with revenues of $1 billion to $1.02 billion this quarter. Insulet – Insulet’s stock, which manufactures insulin delivery systems, has reduced 2.8% after seeking first quarter revenue growth of 22% to 25%, with a slight bottom edge under a fact set consensus of 23.1% per FactSet It came out in. However, Insulet’s fourth quarter results exceeded top and final expectations. Block – The stock lost 17.2% after Block reported disappointing earnings and earnings for the fourth quarter. The Fintech company posted adjusted earnings of 71 cents per share with revenue of $6.03 billion, while Analyst predicted revenue of 87 cents with revenue of $62.9 billion. Rivian Automotive – The electric car maker’s stock has slid 5% after the company predicted lower delivery in 2025. During the period, the company expects to deliver 51,000 units from 46,000 units, less than 51,579 units delivered last year. However, fourth quarter revenues surpassed Wall Street estimates. Libian was looking at its first total quarterly profit. – CNBC’s Alex Hurling, Hakyung Kim, Sean Conlon, Lisa Han and Michelle Fox reported.